You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb2663595 |
---|---|
Category | Small Molecules |
Description | LS-106 is an orally active, effective epidermal growth factor receptor (EGFR) inhibitor displaying antitumor activity both in vitro and in vivo. It inhibits the kinase activities of EGFR19del/T790M/C797S and EGFRL858R/T790M/C797S, with IC50 values of 2.4 nmol/L and 3.1 nmol/L, respectively, demonstrating stronger inhibition than Osimertinib. LS-106 induces cell apoptosis (Apoptosis), suppresses the proliferation of tumor cells carrying EGFR19del/T790M/C797S, and results in significant tumor reduction in a C797S mutant xenograft model. |
Purity | 98.00% |
MW | 548.84 |
Formula | C24H28BrClN5OP |
Storage | -20°C |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |